Methylation of the RUNX3 Promoter as a Potential Prognostic Marker for Bladder Tumor

Journal of Urology

Volumn 180, Issue 3, 2008, Pages 1141-1145

  Kim, Eun Jung ^a   Kim, Yong June ^a   Jeong, Pildu ^a   Ha, Yun Sok ^a   Bae, Suk Chul ^a   Kim, Wun Jae ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

biological; carcinoma; human; methylation; Runx3 protein; transitional cell; tumor markers; urinary bladder

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DNA SEQUENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POINT MUTATION; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 48649097939     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.05.002     Document Type: Article

References (20)

1. Habuchi T., Marberger M., Droller M.J., Hemstreet III G.P., Grossman H.B., Schalken J.A., et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66 (2005) 64
2. Liou L.S. Urothelial cancer biomarkers for detection and surveillance. Urology 67 (2006) 25
3. Baylin S.B., and Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16 (2000) 168
4. Ohtani-Fujita N., Dryja T.P., Rapaport J.M., Fujita T., Matsumura S., Ozasa K., et al. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet 98 (1997) 43
5. Horikawa Y., Sugano K., Shigyo M., Yamamoto H., Nakazono M., Fujimoto H., et al. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. J Urol 169 (2003) 1541
6. Kim W.J., Kim E.J., Jeong P., Quan C., Kim J., Li Q.L., et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65 (2005) 9347
7. Maruyama R., Toyooka S., Toyooka K.O., Harada K., Virmani A.K., Zochbauer-Muller S., et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61 (2001) 8659
8. Catto J.W., Azzouzi A.R., Rehman I., Feeley K.M., Cross S.S., Amira N., et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23 (2005) 2903
9. Yates D.R., Rehman I., Abbod M.F., Meuth M., Cross S.S., Linkens D.A., et al. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 13 (2007) 2046
10. Sathyanarayana U.G., Maruyama R., Padar A., Suzuki M., Bondaruk J., Sagalowsky A., et al. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 64 (2004) 1425
11. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23 (2004) 4198
12. Kim W.J., and Bae S.C. Molecular biomarkers in urothelial bladder cancer. Cancer Sci 99 (2008) 646
13. Bae S.C., and Lee Y.H. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene 366 (2006) 58
14. Li Q.L., Kim H.R., Kim W.J., Choi J.K., Lee Y.H., Kim H.M., et al. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314 (2004) 223
15. Wada M., Yazumi S., Takaishi S., Hasegawa K., Sawada M., Tanaka H., et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 23 (2004) 2401
16. Xiao W.H., and Liu W.W. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 10 (2004) 376
17. Sylvester R.J., van der Meijden A.P., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466
18. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 (2002) 113
19. Spruck III C.H., Ohneseit P.F., Gonzalez-Zulueta M., Esrig D., Miyao N., Tsai Y.C., et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54 (1994) 784
20. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21 (1999) 103